KSQ Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- KSQ Therapeutics's estimated annual revenue is currently $15.7M per year.
- KSQ Therapeutics received $80.0M in venture funding in October 2018.
- KSQ Therapeutics's estimated revenue per employee is $201,000
- KSQ Therapeutics's total funding is $156M.
Employee Data
- KSQ Therapeutics has 78 Employees.
- KSQ Therapeutics grew their employee count by -38% last year.
KSQ Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP, Head Oncology | Reveal Email/Phone |
3 | VP, Head Biochemistry & Biophysics | Reveal Email/Phone |
4 | VP, Financial Planning & Analysis | Reveal Email/Phone |
5 | VP, Head Non Clinical | Reveal Email/Phone |
6 | Head Quality | Reveal Email/Phone |
7 | SVP | Reveal Email/Phone |
8 | VP, Head Computational Biology and Data Science | Reveal Email/Phone |
9 | VP, Target Discovery | Reveal Email/Phone |
10 | Director, Computational Biology at KSQ Therapeutics, Inc | Reveal Email/Phone |
KSQ Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $413.3M | 324 | 0% | $634M | N/A |
#2 | $47.8M | 238 | 0% | N/A | N/A |
#3 | $2.4M | 12 | -52% | N/A | N/A |
#4 | $25.7M | 128 | 39% | N/A | N/A |
#5 | $12.9M | 64 | 129% | N/A | N/A |
#6 | $23.9M | 119 | 8% | $113M | N/A |
#7 | $0.3M | 3 | 0% | N/A | N/A |
#8 | $10.3M | 51 | -14% | N/A | N/A |
#9 | $1.8M | 367 | -4% | $538M | N/A |
#10 | $50M | 249 | 3% | N/A | N/A |
What Is KSQ Therapeutics?
KSQ Therapeutics has built an industry-leading genome-scale precision functional genomics platform, called CRISPRomics, to pinpoint therapeutic nodes that directly correlate genomic function to disease with unprecedented certainty and speed. The company is deploying CRISPRomics for novel drug development across broad therapeutic areas and is currently advancing a proprietary pipeline of tumor- and immune-focused drug candidates. KSQ was founded by thought leaders in the field of functional genomics and pioneers of CRISPR screening technologies, and the company is located in Cambridge, Massachusetts. For more information, please visit the company's website at www.ksqtx.com.
keywords:N/A
$156M
Total Funding
78
Number of Employees
$15.7M
Revenue (est)
-38%
Employee Growth %
N/A
Valuation
N/A
Accelerator
KSQ Therapeutics News
... both as a single agent and in combination with PARP inhibitors, Andrew Wylie, PhD, from KSQ Therapeutics, said in a statement.
KSQ Therapeutics is advancing a pipeline of tumor- and immune-focused drug candidates to treat cancer and autoimmune disease across multiple...
... (AVIR); Denali Therapeutics (DNLI); Rubius Therapeutics (RUBY); Syros Pharmaceuticals (SYRS); Sana Biotechnology; KSQ Therapeutics; ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--KSQ Therapeutics today announced the appointment of Beni B. Wolf, MD, PhD, as Chief Medical ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- KSQ Therapeutics today announced the appointment of Douglas Pagán as Chief Financial Officer.
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $11.3M | 78 | 56% | N/A |
#2 | $12.1M | 78 | 37% | N/A |
#3 | $12.1M | 78 | 5% | N/A |
#4 | $22.6M | 78 | 7% | N/A |
#5 | $8M | 78 | 3% | N/A |
KSQ Therapeutics Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2017-10-03 | $76.0M | Undisclosed | Multiple | Article |
| 2018-10-01 | $80.0M | C | Multiple | Article |